Reports by quarter

Reports submitted in 2024-Q1 · page 3

Backfill quarter. Reports assayed earlier were accepted retrospectively where custody could be documented. Median purity for the quarter is 99.09 % area, n=163. Read the 2024-Q1 state-of-the-index report →

163 records5 pagesmedian on this page 99.06 %updated 30 Jul 2026

Report	Compound	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2024-004153	Desmopressin	WWB	WWB-2312-E2908	Janoshik	2024-Q1	99.79	5.71	—	Supplier-supplied	0	PASS
AX-2024-005372	Semaglutide	CPC	CPC-2309-A2449	Janoshik	2024-Q1	97.53	5.04	103.6	Supplier-supplied	1	MARGINAL
AX-2024-004132	Semax	WWB	WWB-2308-N1754	Janoshik	2024-Q1	99.13	5.11	94.6	Laboratory-retained	0	PASS
AX-2024-005446	Tirzepatide	WXT	WXT-2402-L6189	Medutest	2024-Q1	96.98	6.48	—	Buyer-sourced	1	FAIL
AX-2024-004340	PT-141 (Bremelanotide)	QSC	QSC-2402-X7410	Kestrel	2024-Q1	99.93	3.50	91.0	Supplier-supplied	0	PASS
AX-2024-004204	IGF-1 LR3	WWB	WWB-2310-A4053	Janoshik	2024-Q1	98.78	5.34	—	Supplier-supplied	0	PASS
AX-2024-005299	Semaglutide	GL Biochem	GLBI-2401-F8702	Janoshik	2024-Q1	98.97	3.21	—	Supplier-supplied	1	MARGINAL
AX-2024-005513	Afamelanotide	BCH	BCH-2310-K7610	Janoshik	2024-Q1	98.16	5.48	100.9	Supplier-supplied	0	PASS
AX-2024-005368	Semaglutide	CPC	CPC-2309-A2449	Janoshik	2024-Q1	97.87	4.68	94.6	Supplier-supplied	1	MARGINAL
AX-2024-004849	Retatrutide	HJ	HJ-2309-J4137	Medutest	2024-Q1	98.49	6.46	89.1	Supplier-supplied	3	MARGINAL
AX-2024-004778	N-Acetyl Semax Amide	Homopeptide	HOMO-2401-X1480	VendorInvestigate	2024-Q1	98.61	8.72	93.0	Buyer-sourced	0	PASS
AX-2024-004758	TB-500	Homopeptide	HOMO-2308-R8982	Janoshik	2024-Q1	99.23	3.53	98.5	Supplier-supplied	3	MARGINAL
AX-2024-004680	Tirzepatide	TFC	TFC-2401-J7929	Nordanalyt	2024-Q1	98.35	6.02	95.2	Supplier-supplied	2	MARGINAL
AX-2024-004415	Melanotan II	QSC	QSC-2402-L8184	Janoshik	2024-Q1	99.70	6.40	89.5	Supplier-supplied	3	MARGINAL
AX-2024-004129	Semax	WWB	WWB-2308-N1754	Janoshik	2024-Q1	99.93	5.66	94.6	Supplier-supplied	1	MARGINAL
AX-2024-005356	Semax	CPC	CPC-2309-M1969	Janoshik	2024-Q1	98.23	6.72	—	Supplier-supplied	0	FAIL
AX-2024-004773	N-Acetyl Semax Amide	Homopeptide	HOMO-2401-X1480	PeptideMeter	2024-Q1	99.18	7.82	98.3	Supplier-supplied	0	PASS
AX-2024-005367	Semaglutide	CPC	CPC-2309-A2449	VendorInvestigate	2024-Q1	97.04	5.17	97.0	Buyer-sourced	1	MARGINAL
AX-2024-004847	Retatrutide	HJ	HJ-2309-J4137	Janoshik	2024-Q1	98.86	6.64	—	Supplier-supplied	2	MARGINAL
AX-2024-004521	Gonadorelin	FGP	FGP-2309-U2616	Medutest	2024-Q1	99.04	5.08	106.7	Supplier-supplied	0	PASS
AX-2024-004249	Afamelanotide	WWB	WWB-2312-P4483	Janoshik	2024-Q1	99.77	3.22	—	Supplier-supplied	1	MARGINAL
AX-2024-004572	Semaglutide	JEEP	JEEP-2308-J3560	Janoshik	2024-Q1	99.03	5.25	104.6	Supplier-supplied	1	MARGINAL
AX-2024-004770	N-Acetyl Semax Amide	Homopeptide	HOMO-2401-X1480	VendorInvestigate	2024-Q1	98.85	8.52	—	Buyer-sourced	0	PASS
AX-2024-004242	Afamelanotide	WWB	WWB-2312-P4483	Nordanalyt	2024-Q1	99.77	3.01	100.9	Supplier-supplied	1	MARGINAL
AX-2024-004203	IGF-1 LR3	WWB	WWB-2310-A4053	Medutest	2024-Q1	99.51	4.99	96.0	Supplier-supplied	0	PASS
AX-2024-005371	Semaglutide	CPC	CPC-2309-A2449	Janoshik	2024-Q1	97.42	4.45	90.0	Supplier-supplied	2	MARGINAL
AX-2024-004681	Tirzepatide	TFC	TFC-2401-J7929	Janoshik	2024-Q1	98.01	5.69	94.4	Supplier-supplied	2	MARGINAL
AX-2024-004571	Semaglutide	JEEP	JEEP-2308-J3560	VendorInvestigate	2024-Q1	98.19	4.38	—	Buyer-sourced	0	PASS
AX-2024-004126	Semax	WWB	WWB-2308-N1754	Janoshik	2024-Q1	99.77	5.49	88.8	Supplier-supplied	2	MARGINAL
AX-2024-004121	Semax	WWB	WWB-2308-N1754	VendorInvestigate	2024-Q1	98.89	4.92	96.0	Buyer-sourced	0	PASS
AX-2024-005330	GHRP-6	SGN	SGN-2401-B9048	Janoshik	2024-Q1	99.17	4.88	—	Supplier-supplied	1	MARGINAL
AX-2024-005309	Semaglutide	GL Biochem	GLBI-2401-F8702	Medutest	2024-Q1	99.36	3.21	—	Supplier-supplied	1	MARGINAL
AX-2024-004419	Tirzepatide	QSC	QSC-2402-H8701	Medutest	2024-Q1	99.09	2.61	—	Supplier-supplied	1	MARGINAL
AX-2024-004345	PT-141 (Bremelanotide)	QSC	QSC-2402-X7410	Janoshik	2024-Q1	99.84	3.77	—	Supplier-supplied	0	PASS
AX-2024-004339	PT-141 (Bremelanotide)	QSC	QSC-2402-X7410	Janoshik	2024-Q1	99.80	3.80	88.9	Supplier-supplied	1	MARGINAL
AX-2024-004246	Afamelanotide	WWB	WWB-2312-P4483	Janoshik	2024-Q1	99.09	3.29	—	Laboratory-retained	1	MARGINAL
AX-2024-004202	IGF-1 LR3	WWB	WWB-2310-A4053	Janoshik	2024-Q1	99.14	5.25	99.0	Supplier-supplied	0	PASS
AX-2024-004774	N-Acetyl Semax Amide	Homopeptide	HOMO-2401-X1480	Nordanalyt	2024-Q1	99.50	8.32	100.0	Supplier-supplied	0	PASS
AX-2024-004683	Tirzepatide	TFC	TFC-2401-J7929	VendorInvestigate	2024-Q1	96.82	7.03	—	Buyer-sourced	3	FAIL
AX-2024-004422	Tirzepatide	QSC	QSC-2402-H8701	Nordanalyt	2024-Q1	99.45	1.71	—	Supplier-supplied	1	MARGINAL